Search
Zerencotrep
go.drugbank.com/drugs/DB21710ExperimentalZerencotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Zerencotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.
norUrsodeoxycholic acid
go.drugbank.com/drugs/DB16260InvestigationalnorUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).
Poseltinib
go.drugbank.com/drugs/DB16299InvestigationalPoseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).
Sodelglitazar
go.drugbank.com/drugs/DB16332InvestigationalSodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).
EMI-137
go.drugbank.com/drugs/DB19174InvestigationalEMI-137 is under investigation in clinical trial NCT03360461 (EMI-137 in Laparoscopic Colonic Resections).
Ziresovir
go.drugbank.com/drugs/DB15145InvestigationalZiresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).
Thyrotropin
go.drugbank.com/drugs/DB15263InvestigationalThyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).
Troriluzole
go.drugbank.com/drugs/DB15079InvestigationalTroriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).
Dimethyltryptamine
go.drugbank.com/drugs/DB01488IllicitInvestigationalAn N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. … It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.
Synonyms: N,N-dimethyltryptamine, N,N-dimethyl-1H-indole-3-ethylamineTersolisib
go.drugbank.com/drugs/DB21752InvestigationalSTX-478 is under investigation in clinical trail NCT05768139 (First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors